Search results for Boehringer Ingelheim - Clinical Trials Registry - ICH GCP

Example: Heart Attack

Clinical Trials Sponsored by Boehringer Ingelheim

Total 2390 results

NCT05512377

Recruiting

Brightline-2: A Study to Test Whether BI 907828 Helps People With Cancer in the Biliary Tract, Pancreas, Lung or Bladder

Conditions: Pancreatic Neoplasms, Solid Tumors, Biliary Tract Cancer, Lung Neoplasms
NCT05130463

Recruiting

Esgliteo Post Marketing Surveillance (PMS) in Korean Patients With Type 2 Diabetes Mellitus

Conditions: Diabetes Mellitus, Type 2
NCT05708599

Not yet recruiting

A Study to Compare Tissue and Liquid Biopsies in People With Different Types of Cancer

Conditions: Non-Small-Cell Lung Carcinoma, Colorectal Cancer, Pancreatic Ductal Adenocarcinoma
NCT03099174

Active, not recruiting

This Study in Patients With Different Types of Cancer (Solid Tumours) Aims to Find a Safe Dose of Xentuzumab in Combination With Abemaciclib With or Without Hormonal Therapies. The Study Also Tests How Effective These Medicines Are in Patients With Lung and Breast Cancer.

Conditions: Neoplasms, Breast Neoplasms
NCT04835714

Terminated

A Study to Find a Safe and Effective Dose of BI 1701963 Alone and in Combination With BI 3011441 in Patients With Advanced Cancer and a Certain Mutation (Kirsten Rat Sarcoma Viral Oncogene Homologue [KRAS])

Conditions: Solid Tumors, KRAS Mutation
NCT05613777

Recruiting

A Study in Healthy Women to Test Whether BI 425809 Influences the Amount of a Contraceptive in the Blood

Conditions: Healthy
NCT05471856

Recruiting

A Study to Test How Different Doses of BI 1703880 in Combination With Ezabenlimab Are Tolerated in People With Different Types of Advanced Cancer (Solid Tumours)

Conditions: Solid Tumors
NCT05707403

Not yet recruiting

A Study in Healthy Men to Test How BI 1015550 is Taken up and Handled by the Body

Conditions: Healthy
NCT04093024

Completed

A Study to Find Out How Nintedanib is Taken up in the Body and How Well it is Tolerated in Children and Adolescents With Interstitial Lung Disease (ILD)

Conditions: Lung Diseases, Interstitial
NCT05559580

Recruiting

A Study in People With Systemic Sclerosis to Test Whether BI 685509 Has an Effect on Lung Function and Other Systemic Sclerosis Symptoms

Conditions: Scleroderma, Systemic
NCT04846868

Recruiting

Clinical Trial of Iclepertin Effect on Cognition and Functional Capacity in Schizophrenia (CONNEX-1)

Conditions: Schizophrenia
NCT05151640

Not yet recruiting

INCHANGE - Nintedanib for Changes in Cough and Dyspnea in Patients Suffering From Chronic Fibrosing Interstitial Lung Disease With a Progressive Phenotype in Everyday Clinical Practice: a Real-world Evaluation

Conditions: Lung Diseases, Interstitial
NCT04493424

Active, not recruiting

A Study to Test Long-term Treatment With Spesolimab in People With Palmoplantar Pustulosis (PPP) Who Took Part in Previous Studies With Spesolimab

Conditions: Palmoplantar Pustulosis
NCT05701176

Recruiting

A Clinical Imaging Study of the Changes in [18F]F-AraG Uptake Following Anti-PD-1 Therapy in Non-small Cell Lung Cancer

Conditions: Advanced Stage Non-small Cell Lung Cancer
NCT05633862

Recruiting

A Study in Healthy Chinese People to Test How Different Doses of BI 1015550 Are Taken up in the Body

Conditions: Healthy
NCT05440799

Recruiting

A Study to Test How Healthy Women Tolerate Different Doses of BI 1819479

Conditions: Healthy
NCT05350202

Recruiting

Emp-Activity: Empagliflozin Functional Capacity

Conditions: Heart Failure
NCT05676112

Not yet recruiting

Safety of Nintedanib in Real World in China

Conditions: Pulmonary Fibrosis
NCT05182840

Active, not recruiting

A Study to Test Whether Different Doses of BI 690517 Alone or in Combination With Empagliflozin Improve Kidney Function in People With Chronic Kidney Disease

Conditions: Kidney Disease, Chronic
NCT03594110

Active, not recruiting

EMPA-KIDNEY (The Study of Heart and Kidney Protection With Empagliflozin)

Conditions: Chronic Kidney Disease
NCT04750577

Completed

A Study to Test the Effect of Different Doses of BI 685509 on Kidney Function in People With Diabetic Kidney Disease

Conditions: Diabetic Nephropathies
NCT02632721

Completed

A Trial to Find and Investigate a Safe Dose of BI 836858 in Combination With Decitabine for Patients With Acute Myeloid Leukemia (AML)

Conditions: Leukemia, Myeloid, Acute
NCT05238675

Recruiting

A Study to Test Whether Different Doses of BI 1291583 Help People With Bronchiectasis

Conditions: Bronchiectasis
NCT05161481

Recruiting

A Study to Test Whether Two Different Doses of BI 685509 Help People With Liver Cirrhosis and High Blood Pressure in the Portal Vein (Main Vessel Going to the Liver)

Conditions: Hypertension, Portal
NCT05103657

Recruiting

A Study to Test Whether Taking BI 1358894 for 8 Weeks Helps Adults With Post-traumatic Stress Disorder

Conditions: Post-Traumatic Stress Disorder